![]() |
市场调查报告书
商品编码
1338554
药用明胶市场- 副产品(A型、B型)、来源(猪、牛、鱼、家禽)、功能(稳定剂、增稠剂、胶凝剂、成膜)、应用(胶囊、片剂、可吸收止血剂)、全球预测2023-2032Pharmaceutical Gelatin Market - By Product (Type A, Type B), Source (Porcine, Bovine, Fish, Poultry), Function (Stabilizers, Thickeners, Gelling Agents, Film Forming), Application (Capsules, Tablets, Absorbable hemostats), Global Forecast 2023-2032 |
2023年至2032年,全球药用明胶市场将出现显着增长。老年人口的不断扩大和健康问题的日益严重,推动了对明胶软胶囊作为首选剂型的需求。根据联合国数字图书馆的数据,到 2020 年,全球 65 岁及以上人口估计为 7.27 亿。到 2050 年,这一数字预计将增加一倍以上,达到超过 15 亿人。预计世界人口中老龄化人口的比例将从 2020 年的 9.3% 上升至 2050 年的 16%。到本世纪中叶,全球六分之一的人口将达到 65 岁或以上。
製药和营养保健品行业对封装和控释系统的需求不断增长,推动了明胶胶囊的使用。明胶在药物输送系统(包括微囊化和缓释製剂)中的多功能性推动了其应用。此外,严格的质量标准、药品创新和药品生产的全球增长有助于药用明胶市场的持续扩张。
整个药用明胶市场根据产品、来源、功能和地区进行分类。
根据产品情况,A 类细分市场规模将在 2023 年至 2032 年期间显着扩大。 A 型明胶源自胶原蛋白的酸水解,由于其优异的胶凝和粘合特性,在製药和营养保健品应用中得到广泛应用。它通常用于生产胶囊、片剂和其他口服剂型。对 A 型明胶的高需求凸显了其在药物输送系统和製剂开发中的重要性,使其成为药用明胶市场的重要组成部分。
从来源来看,从 2023 年到 2032 年,鱼类领域的药用明胶市场份额将显着扩大。从鱼皮和鱼骨中获得的鱼明胶提供了哺乳动物明胶来源的替代品。它的吸引力在于它与不同宗教和饮食要求的兼容性,使其适合更广泛的消费者群体。随着消费者偏好转向非哺乳动物来源,胶囊和包衣等医药应用中对鱼明胶的需求持续增长,推动了其重要性。
就功能而言,鱼明胶行业的成膜部分将在2023-2032年对市场收入做出重大贡献。明胶能够形成柔韧且生物相容的薄膜,使其成为片剂、胶囊和其他医药产品包衣的首选。这些薄膜包衣具有多种用途,包括掩味、控释和保护活性成分。随着製药公司致力于创新剂型和改善患者体验,对明胶成膜能力的需求仍然很高。
从区域来看,由于该地区製药和营养保健品行业的强劲以及胶囊和片剂配方对高质量明胶的需求,到 2032 年,欧洲药用明胶市场将录得可观的估值。对安全有效的药物输送系统的严格监管要求鼓励明胶在製药应用中的使用。此外,对可持续采购和製造工艺的日益重视与明胶的天然来源相一致,进一步增加了其在欧洲药用明胶市场的需求。
Global Pharmaceutical Gelatin Market will record a significant growth rate from 2023 to 2032. The expanding elderly population and rising health concerns drive the demand for gelatin-based soft gel capsules as a preferred dosage form. According to the United Nations Digital Library, around the world, there were an estimated 727 million people aged 65 or older in 2020. By 2050, this figure is anticipated to more than double, reaching over 1.5 billion people. The percentage of aging people in the world's population is predicted to rise from 9.3% in 2020 to 16% in 2050. One in six persons worldwide will be 65 years of age or older by the middle of the century.
The increasing pharmaceutical and nutraceutical industries' demand for encapsulation and controlled-release systems fuels the use of gelatin capsules. Gelatin's versatility in drug delivery systems, including microencapsulation and sustained-release formulations, propels its adoption. Additionally, stringent quality standards, pharmaceutical innovations, and the global growth of pharmaceutical production contribute to the Pharmaceutical Gelatin Market's continuous expansion.
The overall Pharmaceutical Gelatin Market is classified based on product, source, function, and region.
Based on the product, the type A segment size will register noticeable expansion throughout 2023-2032. Type A gelatin is derived from the acid hydrolysis of collagen and finds extensive use in pharmaceutical and nutraceutical applications due to its excellent gelling and binding properties. It's commonly used in the production of capsules, tablets, and other oral dosage forms. The high demand for Type A gelatin underscores its significance in drug delivery systems and formulation development, making it a vital component of the pharmaceutical gelatin market.
By source, the pharmaceutical gelatin market share from the fish segment will expand noticeably from 2023 to 2032. Fish gelatin obtained from fish skin and bones offers an alternative to mammalian gelatin sources. Its appeal lies in its compatibility with diverse religious and dietary requirements, making it suitable for a broader consumer base. As consumer preferences shift toward non-mammalian sources, the demand for fish gelatin in pharmaceutical applications, such as capsules and coatings, continues to grow, driving its prominence.
Regarding the function, the film-forming segment of the fish gelatin industry will contribute significantly to the market revenue over 2023-2032. Gelatin's ability to create flexible and biocompatible films makes it a preferred choice for coating tablets, capsules, and other pharmaceutical products. These film coatings serve various purposes, including taste masking, controlled release, and protection of active ingredients. As pharmaceutical companies strive for innovative dosage forms and improved patient experiences, the demand for gelatin's film-forming capabilities remains high.
Regionally, the Europe pharmaceutical gelatin market will record an appreciable valuation by 2032 due to the region's robust pharmaceutical and nutraceutical industries and the need for high-quality gelatin for capsule and tablet formulations. Stringent regulatory requirements for safe and effective drug delivery systems encourage the use of gelatin in pharmaceutical applications. Additionally, the growing emphasis on sustainable sourcing and manufacturing processes aligns with gelatin's natural origin, further boosting its demand in the European pharmaceutical gelatin market.